Events

Complications in Andrology Webinar

Sunday, 27th December 2020 from 1000 – 1300 hrs. USI – ISU webinar  “Complications in Urology” is being held on Sunday, 27th December 2020 from 1000 – 1300 hrs. Please find attached the brochure with the detailed scientific agenda for your perusal.The link to register for the webinar is https://mymedisage.com/live_event_register/USI20 Convenor: Dr. Raman Tanwar Program Opening remarks: Dr. Rajeev TP, Hony, Secretary, […]

Scientific Writing Webinar 2020

Sunday, 13th December 2020, 6 PM USI and IJU Webinar: Scientific writing-the wider perspective SpeakersB. Gitanjali, Director AIIMS BhubaneshwarRajeev Kumar, Editor Indian Journal of UrologyRakesh Aggarwal, Director JIPMER PuducherryPeush Sahni, Editor National Medical Journal of IndiaJohn Davis, Associate Editor BJU InternationalNithya Gogtay, Former Editor JPGMSanjay Pai, Editor Indian Journal of CancerJoseph Smith, Editor Journal of […]

Bladder Pain Syndrome

28th November 2020, 1800-2100 Hrs Topics to be covered The Enigma of Nomenclature – The pathogenic pathways – Bladder and beyond – Hunner’s lesion – The journey of a century – The Biomarkers – Clinical application – Expert comments : Cystoscopy in BPS – The controversies – Ablation of Hunner’s lesions –current recommendations – Intravesical […]

Global Pediatric Urology “Point of Technique” Webinar

8th November 2020To join the webinar please register at: http://exiweb.live/IpcaUrology/ Programme Details :  Opening remarks & Introduction (6:00 to 6: 10 PM) Inaugural session : 10 mins Opening remark by USI secretary Dr. Rajeev T P : 2mins Address by USI president Dr. Anant Kumar :  2 mins Address by ISU president Dr. Rajeev Sood   :  2 mins Address by […]

Diagnostic modalities in Ca Prostate: Do we have too many or too less?

13th September, 2020 1000 – 1300 hrs Prostate carcinoma continues to be an enigma for uro-oncologists the world over. With the varied presentations and the myriad of diagnostic modalities available, and an ever increasing molecular and genomic markers, we need to revisit the appropriate diagnostic workup. How do the genomic biomarkers add to the management […]

Scroll to top